Tropical infections in the ICU

Journal of Association of Physicians of India

Volumn 54, Issue APR., 2006, Pages 291-298

  Kothari, Vatsal M ^a   Karnad, Dilip R ^a   Bichile, Lata S ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

WATER;

ANIMAL; DENGUE; EPIDEMIC ENCEPHALITIS; HUMAN; INFECTION; INTENSIVE CARE UNIT; LEPTOSPIROSIS; MALARIA FALCIPARUM; MICROBIOLOGY; PARASITOLOGY; REVIEW; TROPIC CLIMATE; TYPHUS; UTILIZATION REVIEW; VIROLOGY; VIRUS INFECTION;

ANIMALS; DENGUE; ENCEPHALITIS, JAPANESE; HANTAVIRUS INFECTIONS; HUMANS; INFECTION; INTENSIVE CARE UNITS; LEPTOSPIROSIS; MALARIA, FALCIPARUM; TROPICAL CLIMATE; TYPHUS, EPIDEMIC LOUSE-BORNE; WATER; WATER MICROBIOLOGY;

EID: 33645676310     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Newbold C, Craig A, Kyes S, Rowe A et al Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum. Int J Parasitol 1999;29:927-37.
2. Oh SS, Chishti AH, Palek J. Erythrocyte membrane alterations in Plasmodium falciparum malaria sequestration. Curr Opin Hematol 1997;4:148-54.
3. Idro R, Jenkins NE, Newyon CR. Pathogenesis, clinical features and outcome of cerebral malaria. Lancet Neurol 2005;4: 827-40.
4. Achur RN, Valiyaveettil M, Alkhalil A. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparuminfected erythrocytes to the placenta. J Biol Chem 2000;275:40344-56.
5. TH edn. 1218-33.
6. Cohen C, Karstaedt A, Freari J:Increased prevalence of severe malaria in HIV infected adults in South Africa. Clin Infect Dis 2005;41:1631-7.
7. Krishnan A, Karnad DR. Severe falciparum malaria: An important cause of multiorgan failure in Indian ICU patients. Crit Care Med 2003;31:2278-84.
8. Newlon CRJC, Taylor TE, Whilten RO. Pathophysiology of fatal falciparum malaria in African children. Am J Trop Med Hyg 1998;58:673-83.
9. Katz AR, Ansdell VE, Effler PV. Assessment of the clinical presentation and treatment of 353 cases of laboratory confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 2001;33:1834 41.
10. Vancrevel R, Speelman P, Gravekamp C.: Leptospirosis in travelers. Clinical Infectious Diseases 1994;19:132-4.
11. Bharadwaj R, Bal AM, Joshi SA. An urban outbreak of leptospirosis in Mumbai,India. Jpn J Infect Dis 2002;55: 194-6.
12. Winslow WE, Merry DJ, Pire ML. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. J Clin Microbiol 1997;35:1.938-42.
13. Levett PN, Whittington CU. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis. J Clin Microbiol 1998;36:11-4.
14. Watt G, Padre LP, Tuazon ML, Calubaquib C. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433-5.
15. Panaphut T, Domrongkitchaiporn S, Vibhagool A. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 2003;36:1.507-13.
16. Suputtamongkol Y, Niwattayakul K, Suttinont C. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004;39:1417-24.
17. Wu SJ, Grouard-Vogel G, Sun W. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000;6:816-20.
18. Wilder-Smith A, Schwartz E. Dengue in Travellers.NEJM. 2005;353:924-32.
19. Sangkawibha N, Rojanasuphot S, Ahandrik S. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984;120:653-69.
20. Guzman MG, Kouri GP, Bravo J. Dengue homorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 1990;42:179-84.
21. Thisyakorn U, Nimmannitya S. Nutritional status of children with dengue homorrhagic fever. Clin Infect Dis 1993;16: 295-7.
22. Zivria I, Green S, Vaughn DW. T cell responses to an HLA-B*07- restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 2002;168:5959-65.
23. Shah I, Deshpande GC, Tardeja PN.Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome. J Trop Pediatr 2004;50:301-5.
24. Rigau-Perez JG. The early use of break-bone fever (Quebranta huesos, 1771) and dengue (1801) in Spanish. Am J Trop Med Hyg 1998;59:272-4.
25. Kalayanarooj S, Vaughn DW, Nimmannitya S. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997;176:313-21.
26. Solomon T, Dung NM, Vaughn DW. Neurological manifestations of dengue infection. Lancet 2000;355:1053-9.
27. Patey O, Ollivaud L, Breuil J. Unusual neurologic manifestations occurring during dengue fever infection. Am J Trop Med Hyg 1993;48:793-802.
28. Wills BA, Nguyen MD, Ha TL. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877 89.
29. Chandy S, Mitra S, Sathish N. A pilot study for serological evidence of hantavirus infection in human population in South India. Indian J Med Res 2005;122:211-5.
30. Lee HW, van der Groen G. Hemorrhagic fever with renal syndrome. Prog Med Virol 1989;36:62-102.
31. Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 1999;50: 531-45.
32. Linderholm M, Groeneveld PH, Tarnvik A. Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome - relation to arterial hypotension and tumor necrosis factor. Infection 1996;24:337-40.
33. Castillo C, Naranjo J, Sepulveda A. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 2001;120:548-54.
34. Koster F, Foucar K, Hjelle B. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol 2001;110:665-72.
35. Bharadwaj M, Nofchissey R, Goade D. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000;182:43-8.
36. Crowley MR, Katz RW, Kessler R. Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 1998;26:409-14.
37. Mertz GJ, Miedzinski L, Goade D. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004;39:1307-13.
38. Cosgriff TM, Lewis RM. Mechanisms of disease in hemorrhagic fever with renal syndrome. Kidney Int Suppl 1991;35:572-9.
39. Huggins JW, Hsiang CM, Cosgriff TM. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect Dis 1991;164:1119-27.
40. Silpapajakul K, Varachlt P. Pediatric scrub typhus in Thailand: a study of 73 confirmed cases. Trans R Soc Trop Med Hyg 2004;98:354-9.
41. Aronoff DM, Walt G. Prevalence of relative bradycardia in Orientia tsutsugamushi infection. Am J Trop Med Hyg 2003;68:477-9.
42. Strickman D, Sheer T, Salata K. In vitro effectiveness of azilhromycin against doxycycline resistant and susceptible strains of Rickettsia tsutsugarnushi, etiologic agent of scrub typhus. Antimicrob Agents Chemother 1995;39:2406-10.
43. Solomon T. Flavivirus Encephalitis. N Engl J Med 2004;351:370-8.
44. Kalita J, Mishra UK, Pandey S. A comparison of clinical and radiological findings in adults arid children with Japanese encephalitis. Arch Neurol 2003;12:1760-4.
45. Mishra UK, Kalita J, Goel D. Clinical, radiological and electrophysiological spectrum of JEV encephalitis and other non-specific encephalitis during post monsoon period in India. Neurol India 2003;51:55-9.
46. Chauhan S, Jain S, Varma S. Tropical pyornyositis (myositis troplcans): current perspective. Postgraduate Medical Journal 2004;80:267-70.
47. Chiedozi LC. Pyormyositis. Review of 205 cases in 112 patients. Am J Surg 1979;137:255-9.